PRESS RELEASE published on 05/14/2024 at 22:05, 1 year 10 months ago Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress Protagonist Therapeutics to present rusfertide Phase 2 REVIVE study data at EHA Congress in Madrid. Study shows absence of QTc prolongation with rusfertide. Details on pipeline drugs and collaborations available on company's website Clinical Development Collaborations Protagonist Therapeutics Rusfertide EHA Congress
Published on 04/02/2026 at 00:55, 1 hour 40 minutes ago Silver Spruce Resources Inc. Announces Close of $739,250 First Tranche of Non-Brokered Private Placement and Extension
Published on 04/02/2026 at 00:00, 2 hours 35 minutes ago Redwood AI Launches Collaborative Research Project with UBC's Brent Page Lab Focused on Alzheimer's Drug Discovery
Published on 04/01/2026 at 23:15, 3 hours 20 minutes ago Golden Minerals Reports Full Year 2025 Results
Published on 04/01/2026 at 18:15, 8 hours 20 minutes ago Loop Industries to Present at Gabelli Waste & Sustainability Symposium
Published on 04/02/2026 at 00:52, 1 hour 42 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3H
Published on 04/01/2026 at 22:23, 4 hours 11 minutes ago EQS-Adhoc: Deutsche Börse AG: US court grants decision to plaintiffs’ group seeking turnover of assets attributed to Bank Markazi and held by Clearstream
Published on 04/01/2026 at 22:05, 4 hours 30 minutes ago Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers
Published on 04/01/2026 at 22:05, 4 hours 30 minutes ago Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
Published on 04/01/2026 at 19:16, 7 hours 18 minutes ago Mars 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 04/01/2026 at 18:15, 8 hours 20 minutes ago Accor signs a memorandum of understanding on the sale of its stake in Essendi
Published on 04/01/2026 at 18:15, 8 hours 20 minutes ago Accor a signé un protocole d’accord pour la cession de sa participation dans Essendi
Published on 04/01/2026 at 18:02, 8 hours 32 minutes ago CP MOULINVEST : TRANSFERT DU CONTRAT DE LIQUIDITE AUPRES DE TPICAP
Published on 04/01/2026 at 18:00, 8 hours 35 minutes ago Closing of acquisition of Chaplin's World operating company